Cargando…
Retracted: High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307266/ https://www.ncbi.nlm.nih.gov/pubmed/37387918 http://dx.doi.org/10.1155/2023/9876457 |
Ejemplares similares
-
Retracted: Expression of PD-L1 and BRCA1 in Triple-Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: DNA Hypomethylation of DOCK1 Leading to High Expression Correlates with Neurologic Deterioration and Poor Function Outcomes after Spontaneous Intracerebral Hemorrhage
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)